Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice

CNS and Neurological Disorders - Drug Targets

Volumn 12, Issue 1, 2013, Pages 45-54

  Luongo, Livio ^a   Guida, Francesca ^a   Boccella, Serena ^a   Bellini, Giulia ^a   Gatta, Luisa ^a   Rossi, Francesca ^a   de Novellis, Vito ^a   Maione, Sabatino ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Astrocytes; Microglia; Mouse; Neuropathic pain; Palmitoylethanolamide

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; PALMIDROL;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; GLIA CELL; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOUSE; NERVE CONDUCTION; NEUROPATHY; NOCICEPTION; NONHUMAN; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD;

ACTION POTENTIALS; ANIMALS; ENDOCANNABINOIDS; ETHANOLAMINES; FORMALDEHYDE; MALE; MICE; MICE, INBRED ICR; MICROGLIA; NEURALGIA; NEUROGLIA; PAIN MEASUREMENT; PALMITIC ACIDS; PHENOTYPE; SPINAL CORD;

EID: 84875316882     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527311312010009     Document Type: Article

References (49)

1. Bonica, J.J. Treatment of pain and nerve block. Masui., 1970, 19, 1-10.
2. Millan, M.J. The induction of pain: an integrative review. Prog. Neurobiol., 1999, 57(1), 1-164. Review
3. Bennett, J.G.; Xie, Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 1988, 33,87-107.
4. Decosterd, I.; Woolf, C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain, 2000, 87(2), 149-158.
5. Courteix, C.; Eschalier, A.; Lavarenne, J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain, 1993, 53(1), 81-88.
6. Polomano, R.C.; Bennett, G.J. Chemotherapy-evoked painful peripheral neuropathy. Pain Med., 2001, 2(1), 8-14.
7. Di Cesare Mannelli, L.; Zanardelli, M.; Failli, P.; Ghelardini, C.J. Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. Pain, 2012, 13(3), 276-284.
8. Fu, K.Y.; Light, A.R.; Matsushima, G.K.; Maixner, W. Microglial reactions after subcutaneous formalin injection into the rat hind paw. Brain Res., 1999, 17, 825(1-2), 59-67.
9. Tsuda, M.; Shigemoto-Mogami, Y.; Koizumi, S.; Mizokoshi, A.; Kohsaka, S.; Salter, M.W.; Inoue, K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury Nature, 2003, 424, 778-783
10. [Inoue, K. ATP receptors of microglia involved in pain. Novartis Found Symp., 2006, 276, 263-272; discussion 273-281. Review
11. Hains, B.C.; Waxman, S.G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury J. Neurosci., 2006, 26, 308-4317.
12. Tanga, F.Y.; Raghavendra, V.; DeLeo, J.A. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem. Int., 2004, 45, 397-407.
13. Clark, A.K.; Gentry, C.; Bradbury, E.J.; McMahon, S.B.; Malcangio, M. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur. J. Pain, 2008, 11, 223-230
14. Luongo, L.; Palazzo, E.; Tambaro, S.; Giordano, C.; Gatta, L.; Scafuro, M.A.; Rossi, F.S., Lazzari, P.; Pani, L.; de Novellis, V.; Malcangio, M. Maione S 1-(2́,4́-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice. Neurobiol. Dis., 2010, 37, 177-185.
15. Wodarski, R.; Clark, A.K.; Grist, J.; Marchand, F.; Malcangio, M. Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats. Eur. J. Pain., 2009, 13(8), 807-811
16. Luongo, L.; Sajic, M.; Grist, J.; Clark, A.K.; Maione, S.; Malcangio, M. Spinal changes associated with mechanical hypersensitivity in a model of Guillain-Barré syndrome. Neurosci. Lett. 2008, 30, 437(2), 98-102.
17. Fu, K.Y.; Light, A.R.; Maixner, W. Long-lasting inflammation and long-term hyperalgesia after subcutaneous formalin injection into the rat hindpaw. J. Pain, 2001, 2, 2-11.
18. Clark, A.K.; Yip, P.K.; Grist, J.; Gentry, C.; Staniland, A.A.; Marchand, F.; Dehvari, M.; Wotherspoon, G.; Winter, J.; Ullah, J.; Bevan, S.; Malcangio, M. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain Proc. Natl. Acad. Sci. U S A. 2007,19, 104(25), 10655-10660.
19. Stella, N. Endocannabinoid signaling in microglial cells. Neuropharmacology, 2009, 1, 244-253. Rewiew.
20. Racz, I.; Nadal, X.; Alferink, J.; Baños, J.E.; Rehnelt, J.; Martín, M.; Pintado, B.; Gutierrez-Adan, A.; Sanguino, E.; Bellora, N.; Manzanares, J.; Zimmer, A.; Maldonado, R. Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain. J. Neurosci., 2008, 12, 28(46), 12136-12145
21. Costa, B.; Comelli, F.; Bettoni, I.; Colleoni, M.; Giagnoni, G. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors. Pain, 2008, 31, 139(3), 541-550.
22. Walter, L.; Franklin, A.; Witting, A.; Wade, C.; Xie, Y.; Kunos, G.; Mackie, K.; Stella, N. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 2003,15, 23(4), 1398-1405.
23. Franklin, A.; Parmentier-Batteur, S.; Walter, L.; Greenberg, D.A.; Stella, N. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility J. Neurosci., 2003, 23(21), 7767-75.
24. McGaraughty, S.; Chu, K.L.; Perner, R.J.; Didomenico, S.; Kort, M.E.; Kym, P.R. TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats. Mol. Pain, 2010, 5, 6-14.
25. Telleria-Diaz, A.; Schmidt, M.; Kreusch, S.; Neubert, A.K.; Schache, F.; Vazquez, E.; Vanegas, H.; Schaible, H.G.; Ebersberger, A. Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids. Pain, 2009, 148, 26-35.
26. Simone, D.A., Khasabov, S.G.; Hamamoto, D.T. Changes in response properties of nociceptive dorsal horn neurons in a murine model of cancer pain. Sheng Li Xue Bao, 2008, 60, 635-44
27. Guillot, X.; Semerano, L.; Decker, P.; Falgarone, G.; Boissier, M.C. Pain and immunity. Joint Bone Spine. 2012, 79(3), 228-236.
28. Folgueras, A.R.; Valdés-Sánchez, T.; Llano, E.; Menéndez, L.; Baamonde, A.; Denlinger, B.L.; Belmonte, C.; Juárez, L.; Lastra, A.; García-Suárez, O.; Astudillo, A.; Kirstein, M.; Pendás, A.M.; Fariñas, I.; López-Otín, C. Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation. Proc. Natl. Acad. Sci. U S A., 2009, 106(38), 16451-16456
29. Rudick, C.N.; Bryce, P.J.; Guichelaar, L.A.; Berry, R.E.; Klumpp, D.J. Mast cell-derived histamine mediates cystitis pain. PLoS One. 2008, 7, 3(5), e2096
30. Wang, H.; Ehnert, C.; Brenner, G.J.; Woolf, C.J. Bradykinin and peripheral sensitization. Biol. Chem., 2006, 387(1), 11-14. Review.
31. De Filippis, D.; Luongo, L.; Cipriano, M.; Palazzo, E.; Cinelli, M.P.; de Novellis, V.; Maione, S.; Iuvone, T. Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats. Mol. Pain, 2011, 7, 3.
32. Dubuisson, D.; Dennis, S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain, 1977, 4(2), 161-174.
33. Sawynok, J.; Liu, X.J. Adenosine in the spinal cord and periphery: release and regulation of pain. Prog. Neurobiol., 2003, 69(5), 313-340. Review.
34. Fu, K.Y.; Tan, Y.H.; Sung, B.; Mao, J. Peripheral formalin injection induces unique spinal cord microglial phenotypic changes. Neurosci. Lett., 2009, 449(3), 234-239
35. Lin, T.; Li, K.; Zhang, F.Y.; Zhang, Z.K.; Light, A.R.; Fu, K.Y. Dissociation of spinal microglia morphological activation and peripheral inflammation in inflammatory pain models. J. Neuroimmunol., 2007, 192(1-2), 40-48.
36. Vierck, C.J.; Yezierski, R.P.; Light, A.R. Long-lasting hyperalgesia and sympathetic dysregulation after formalin injection into the rat hind paw. Neuroscience. 2008, 153(2), 501-506.
37. Ambriz-Tututi, M.; Rocha-González, H.I.; Castañeda-Corral, G.; Araiza-Saldaña, C.I.; Caram-Salas, N.L.; Cruz, S.L.; Granados-Soto, V. Role of opioid receptors in the reduction of formalin- induced secondary allodynia and hyperalgesia in rats. Eur. J. Pharmacol, 2009, 619(1-3), 25-32
38. Scuderi, C; Valenza, M.; Stecca, C; Esposito, G.; Carratù, M.R.; Steardo, L. Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activatedreceptor-a. J. Neuroinflammation., 2012, 9, 49.
39. Lo Verme, J.; Fu, J.; Astarita, G.; La Rana, G.; Russo, R.; Calignano, A.; Piomelli, D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the antiinflammatory actions of palmitoylethanolamide. Mol. Pharmacol, 2005, 67(1), 15-9.
40. de Novellis, V.; Luongo, L.; Guida, F.; Cristino, L.; Palazzo, E.; Russo, R.; Marabese, I.; D́Agostino, G.; Calignano, A.; Rossi, F.; Di Marzo, V.; Maione, S. Effects of intra-ventrolateral periaqueductal grey palmitoylethanolamide on thermoceptive threshold and rostral ventromedial medulla cell activity. Eur. J. Pharmacol, 2012, 676(1-3), 41-50.
41. Godlewski, G.; Offertáler, L.; Wagner, J.A.; Kunos, G. Receptors for acylethanolamides-GPR55 and GPR119. Prostaglandins Other Lipid Mediat., 2009, 89(3-4), 105-111.
42. Walter, L.; Franklin, A.; Witting, A.; Moller, T.; Stella, N. Astrocytes in culture produce anandamide and other acylethanolamides. J. Biol. Chem., 2002, 277(23), 20869-20876.
43. Muccioli, G.G.; Stella, N. Microglia produce and hydrolyze palmitoylethanolamide. Neuropharmacology, 2008, 54(1), 16-22.
44. Pietr, M.; Kozela, E.; Levy, R; Rimmerman, N.; Lin, Y.H.; Stella, N.; Vogel, Z.; Juknat, A. Differential changes in GPR55 during microglial cell activation. FEBS Lett, 2009, 583(12), 2071-2076.
45. McHugh, D.; Hu, S.S.; Rimmerman, N.; Juknat, A.; Vogel, Z.; Walker, J.M.; Bradshaw, H.B. N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci., 2010, 11, 44.
46. Koch, M.; Kreutz, S.; Böttger, C; Benz, A.; Maronde, E.; Ghadban, C; Korf, H.W.; Dehghani, F. Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-a. Neurotox. Res., 2011, 19(2), 330-340.
47. Coull, J.A.; Beggs, S.; Boudreau, D.; Boivin, D.; Tsuda, M.; Inoue, K.; Gravel, C; Salter, M.W.; De Koninck, Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature, 2005, 438(7070), 1017-1021.
48. Benito, C; Tolón, R.M.; Castillo, A.I.; Ruiz-Valdepeñas, L.; Martínez-Orgado, J.A.; Fernández-Sánchez, F.J.; Vázquez, C; Cravatt, B.F.; Romero, J. p-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-a, PPAR-y and TRPV1, but not CB(1) or CB(2) receptors. Br. J. Pharmacol, 2012, 166(4), 1474-1489.
49. Guida, F.; Luongo, L.; Aviello, G.; Palazzo, E.; De Chiaro, M.; Gatta, L.; Boccella, S.; Marabese, I.; Zjawiony, J.K.; Capasso, R.; Izzo, A.; de Novellis, V.; Maione, S. Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection. Mol. Pain, 2012, 8(1), 60.